Contrast-enhanced Harmonic Endoscopic Ultrasonography with Time-intensity Curve Analysis for Intraductal Papillary Mucinous Neoplasms of the Pancreas
Overview
Pharmacology
Radiology
Authors
Affiliations
Background And Study Aims: Preoperative diagnosis of the pathological grade of intraductal papillary mucinous neoplasms (IPMNs) is difficult. This study aimed to evaluate the accuracy of contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) with time - intensity curve analysis in differentiating between low or intermediate grade dysplasia (LGD/IGD) and high grade dysplasia or invasive carcinoma (HGD/invasive carcinoma) in IPMNs and to assess correlation between the time - intensity curve parameters and tumor microvessel density.
Patients And Methods: Data from 30 patients with resected IPMNs (14 LGD/IGD, 16 HGD/invasive carcinoma) who underwent CH-EUS with time - intensity curve analysis were evaluated retrospectively. Time - intensity curve parameters and the microvessel density of the mural nodule were compared between the HGD/invasive carcinoma and LGD/IGD groups; the diagnostic accuracy of the time - intensity curve parameters was evaluated.
Results: The echo intensity change and echo intensity reduction rate of the mural nodule, and the nodule/pancreatic parenchyma contrast ratio were significantly higher in the HGD/invasive carcinoma group than in the LGD/IGD group (P < 0.05); the accuracies of these parameters were 80 %, 86.7 %, and 93.3 %, respectively. The microvessel density of the mural nodule was significantly higher in the HGD/invasive carcinoma group (P = 0.002). There was a strong positive, linear correlation between the echo intensity change of the mural nodule and the microvessel density (r = 0.803, P < 0.001).
Conclusions: CH-EUS with time - intensity curve analysis is potentially useful for quantitatively evaluating the blood flow of IPMN microvasculature, and for differentiating between HGD/invasive carcinoma and LGD/IGD.
Ohno E, Kuzuya T, Kawabe N, Nakaoka K, Tanaka H, Nakano T DEN Open. 2024; 5(1):e413.
PMID: 39040523 PMC: 11260769. DOI: 10.1002/deo2.413.
Metelli F, Manfredi G, Pagano N, Buscarini E, Crino S, Armellini E Diagnostics (Basel). 2024; 14(12).
PMID: 38928649 PMC: 11202526. DOI: 10.3390/diagnostics14121233.
Yamashita Y, Kitano M Clin Endosc. 2024; 57(2):164-174.
PMID: 38229442 PMC: 10984748. DOI: 10.5946/ce.2023.074.
Ohno E, Kuzuya T, Kawabe N, Nakaoka K, Tanaka H, Nakano T J Med Ultrason (2001). 2023; .
PMID: 37924442 DOI: 10.1007/s10396-023-01376-x.
Color overlay of contrast-enhanced endoscopic ultrasound for pancreaticobiliary disease.
Toyonaga H, Hayashi T, Motoya M, Kin T, Takahashi K, Katanuma A Endoscopy. 2023; 55(S 01):E1111-E1113.
PMID: 37802115 PMC: 10558281. DOI: 10.1055/a-2164-0850.